Glenn D Osborne

US Patent:

8107693, Jan 31, 2012

Filed:

Apr 7, 2006

Appl. No.:

11/399733

Inventors:

Glenn F. Osborne - Davis CA, US
Simon S. M. Chin - Saratoga CA, US
Paul McDonald - Saratoga CA, US
Scott Schneider - Saratoga CA, US

Assignee:

Iris Biotechnologies, Inc. - Santa Clara CA

International Classification:

G06K 9/00

US Classification:

382128

Abstract:

The present invention provides a complete artificial intelligence system for the acquisition and analysis of nucleic acid array hybridization information. The system includes a central data processing facility and one or more user facilities, linked by encrypted connections. Each user facility may include an optical scanning system to collect hybridization signals from a nucleic acid array, an image processing system to convert the optical data into a set of hybridization parameters, a connection to a data network, and a user interface to display, manipulate, search, and analyze hybridization information. This system reads data from a nucleic acid microarray, analyzes test results, evaluates patient risk for various ailments, and recommends methods of treatment. The automated artificial intelligence system is a real time, dynamic decision making tool that can be used in conjunction with a clinical analysis system, and with the information obtained in a research and development environment.

US Patent:

20070186169, Aug 9, 2007

Filed:

Feb 9, 2006

Appl. No.:

11/352116

Inventors:

Glenn Osborne - Davis CA, US
John Anderson - Citrus Heights CA, US
Mark Wright - Colfax CA, US

International Classification:

G06F 15/177
G06F 9/44
G06F 15/173
H04L 12/26

US Classification:

715734000, 717124000, 709223000, 370241000

Abstract:

Methods and systems for managing and testing networks.

US Patent:

20120177261, Jul 12, 2012

Filed:

Jan 12, 2012

Appl. No.:

13/349225

Inventors:

GLENN F. OSBORNE - Davis CA, US
Simon S. M. Chin - Saratoga CA, US
Paul McDonald - Saratoga CA, US
Scott Schneider - Saratoga CA, US

International Classification:

G06K 9/62

US Classification:

382128, 382110

Abstract:

The present invention provides a complete artificial intelligence system for the acquisition and analysis of nucleic acid array hybridization information. The system includes a central data processing facility and one or more user facilities, linked by encrypted connections. Each user facility may include an optical scanning system to collect hybridization signals from a nucleic acid array, an image processing system to convert the optical data into a set of hybridization parameters, a connection to a data network, and a user interface to display, manipulate, search, and analyze hybridization information. This system reads data from a nucleic acid microarray, analyzes test results, evaluates patient risk for various ailments, and recommends methods of treatment. The automated artificial intelligence system is a real time, dynamic decision making tool that can be used in conjunction with a clinical analysis system, and with the information obtained in a research and development environment.

US Patent:

7062076, Jun 13, 2006

Filed:

Aug 28, 2000

Appl. No.:

09/650005

Inventors:

Glenn F. Osborne - Davis CA, US
Simon S. M. Chin - Saratoga CA, US
Paul McDonald - Saratoga CA, US
Scott Schneider - Saratoga CA, US

Assignee:

Iris Biotechnologies, Inc. - Santa Clara CA

International Classification:

G06K 9/00

US Classification:

382128

Abstract:

The present invention provides a complete artificial intelligence system for the acquisition and analysis of nucleic acid array hybridization information. The system is divided into at least one central data processing facility and one or more user facilities, linked by encrypted network connections or similar links. Each user facility may include an optical scanning system to collect hybridization signals from a nucleic acid array, an image processing system to convert the optical data into a set of hybridization parameters, a connection to a data network, and a user interface to display, manipulate, search, and analyze hybridization information. This system reads data from a gene chip or DNA microarray, or a proteomics chip, analyzes test results based on maintained parameters, evaluates patient risk for various ailments, recommends methods of treatment, presents information to medical and/or private individuals, and notifies test participants when new treatment becomes available. The test results may be used to perform individual diagnostics, longitudinal studies, population studies, or a wide variety of statistical analyses of patient data. The automated artificial intelligence system is a real time, dynamic decision making tool that can be used not only in conjunction with a clinical analysis system, but also with the information obtained in a research and development environment.